Dynamic changes of XPA, XPC, XPF, XPG and ERCC1 protein expression and their correlations with levels of DNA damage in human bronchial epithelia cells exposed to benzo[a]pyrene

Toxicology Letters

Volumn 174, Issue 1-3, 2007, Pages 10-17

  Yang, Jin ^a   Liu, Xiaoyong ^a   Niu, Piye ^a   Zou, Yunfeng ^a   Gong, Zhiyong ^a   Yuan, Jing ^a   Wu, Tangchun ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Benzo a pyrene; Human bronchial epithelia cells; Nucleotide excision repair

Indexed keywords

BENZO[A]PYRENE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP F PROTEIN; XERODERMA PIGMENTOSUM GROUP G PROTEIN;

ARTICLE; BRONCHUS MUCOSA; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; EPITHELIUM CELL; EXCISION REPAIR; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BENZO(A)PYRENE; BRONCHI; CELL LINE; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; DNA-BINDING PROTEINS; ENVIRONMENTAL POLLUTANTS; EPITHELIAL CELLS; HUMANS; MUTAGENS;

EID: 35348956514     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.08.004     Document Type: Article

References (38)

1. Athas W.F., Hedayati M.A., Matanoski G.M., Farmer E.R., and Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res. 51 (1991) 5786-5793
2. Benhamou S., and Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat. Res. 462 (2000) 149-158
3. Celotti L., Ferraro P., Furlan D., Zanesi N., and Pavanello S. DNA repair in human lymphocytes treated in vitro with (+)-anti- and (±)-syn-benzo[a]pyrene diolepoxide. Mutat. Res. 294 (1993) 117-126
4. Chang L.C., Sheu H.M., Huang Y.S., Tsai T.R., and Kuo K.W. A novel function of emodin: enhancement of the nucleotide excision repair of UV- and cisplatin-induced DNA damage in human cells. Biochem. Pharmacol. 58 (1999) 49-57
5. Dabholkar M., Bostick-Bruton F., Weber C., Bohr V.A., Egwuagu C., and Reed E. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J. Natl. Cancer Inst. 84 (1992) 1512-1517
6. Dip R., Camenisch U., and Naegeli H. Mechanisms of DNA damage recognition and strand discrimination in human nucleotide excision repair. DNA Repair (Amst) 3 (2004) 1409-1423
7. Evans E., Moggs J.G., Hwang J.R., Egly J.M., and Wood R.D. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 16 (1997) 6559-6573
8. Fairbairn D.W., Olive P.L., and O'Neill K.L. The comet assay: a comprehensive review. Mutat. Res. 339 (1995) 37-59
9. Hecht S.S., Carmella S.G., Murphy S.E., Foiles P.G., and Chung F.L. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J. Cell. Biochem. Suppl. 17F (1993) 27-35
10. Li Q., Yu J.J., Mu C., Yunmbam M.K., Slavsky D., Cross C.L., Bostick-Bruton F., and Reed E. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Anticancer Res. 20 (2000) 645-652
11. Lord R.V., Brabender J., Gandara D., Alberola V., Camps C., Domine M., Cardenal F., Sanchez J.M., Gumerlock P.H., Taron M., Sanchez J.J., Danenberg K.D., Danenberg P.V., and Rosell R. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin. Cancer Res. 8 (2002) 2286-2291
12. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
13. Melton D.W., Ketchen A.M., Nunez F., Bonatti-Abbondandolo S., Abbondandolo A., Squires S., and Johnson R.T. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination. J. Cell Sci. 111 Pt 3 (1998) 395-404
14. Metzger R., Leichman C.G., Danenberg K.D., Danenberg P.V., Lenz H.J., Hayashi K., Groshen S., Salonga D., Cohen H., Laine L., Crookes P., Silberman H., Baranda J., Konda B., and Leichman L. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J. Clin. Oncol. 16 (1998) 309-316
15. Moneef M.A., Sherwood B.T., Bowman K.J., Kockelbergh R.C., Symonds R.P., Steward W.P., Mellon J.K., and Jones G.D. Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity. Br. J. Cancer 89 (2003) 2271-2276
16. O'Donovan A., Davies A.A., Moggs J.G., West S.C., and Wood R.D. XPG endonuclease makes the 3′ incision in human DNA nucleotide excision repair. Nature 371 (1994) 432-435
17. Olive P.L., Banath J.P., and Durand R.E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat. Res. 122 (1990) 86-94
18. Olive P.L., Wlodek D., Durand R.E., and Banath J.P. Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp. Cell Res. 198 (1992) 259-267
19. Park C.H., Bessho T., Matsunaga T., and Sancar A. Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease. J. Biol. Chem. 270 (1995) 22657-22660
20. Pliskova M., Vondracek J., Vojtesek B., Kozubik A., and Machala M. Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. Toxicol. Sci. 83 (2005) 246-256
21. Price M.E., McKelvey-Martin V.J., Robson T., Hirst D.G., and McKeown S.R. Induction and rejoining of DNA double-strand breaks in bladder tumor cells. Radiat. Res. 153 (2000) 788-794
22. Sijbers A.M., de Laat W.L., Ariza R.R., Biggerstaff M., Wei Y.F., Moggs J.G., Carter K.C., Shell B.K., Evans E., de Jong M.C., Rademakers S., de Rooij J., Jaspers N.G., Hoeijmakers J.H., and Wood R.D. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 86 (1996) 811-822
23. Simon G.R., Sharma S., Cantor A., Smith P., and Bepler G. ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Chest 127 (2005) 978-983
24. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
25. Smith L.E., Denissenko M.F., Bennett W.P., Li H., Amin S., Tang M., and Pfeifer G.P. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 92 (2000) 803-811
26. Snow E.T. The role of DNA repair in development. Reprod. Toxicol. 11 (1997) 353-365
27. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., and Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35 (2000) 206-221
28. Tokiwa H., Sera N., Horikawa K., Nakanishi Y., and Shigematu N. The presence of mutagens/carcinogens in the excised lung and analysis of lung cancer induction. Carcinogenesis 14 (1993) 1933-1938
29. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
30. van Duin M., Koken M.H., van den Tol J., ten Dijke P., Odijk H., Westerveld A., Bootsma D., and Hoeijmakers J.H. Genomic characterization of the human DNA excision repair gene ERCC-1. Nucleic Acids Res. 15 (1987) 9195-9213
31. Venema J., van Hoffen A., Karcagi V., Natarajan A.T., van Zeeland A.A., and Mullenders L.H. Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol. Cell Biol. 11 (1991) 4128-4134
32. Vineis P., Kogevinas M., Simonato L., Brennan P., and Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat. Res. 463 (2000) 103-110
33. Vogel U., Dybdahl M., Frentz G., and Nexo B.A. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat. Res. 461 (2000) 197-210
34. Volker M., Mone M.J., Karmakar P., van Hoffen A., Schul W., Vermeulen W., Hoeijmakers J.H., van Driel R., van Zeeland A.A., and Mullenders L.H. Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell 8 (2001) 213-224
35. Warnecke-Eberz U., Metzger R., Miyazono F., Baldus S.E., Neiss S., Brabender J., Schaefer H., Doerfler W., Bollschweiler E., Dienes H.P., Mueller R.P., Danenberg P.V., Hoelscher A.H., and Schneider P.M. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Clin. Cancer Res. 10 (2004) 3794-3799
36. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 65 (1996) 135-167
37. Zhu Z., Zhuang Z., Huang Y., and Ji T. Design and application of image analysis system to single cell gel electrophoresis [in Chinese]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 19 (2001) 298-300
38. Zmirou D., Masclet P., Boudet C., Dor F., and Dechenaux J. Personal exposure to atmospheric polycyclic aromatic hydrocarbons in a general adult population and lung cancer risk assessment. J. Occup. Environ. Med. 42 (2000) 121-126